Wichaiyo S.; Svasti S.; Maiuthed A.; Rukthong P.; Goli A.S.; Morales N.P.
(American Chemical Society, 2023)
Dasatinib, a tyrosine kinase inhibitor, has been shown to produce anti-inflammatory activity and impair vascular integrity in vivo, including during skin wound healing, potentially promoting the repair process. Given that ...